-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2010 to Q1 2025.
- Lexaria Bioscience Corp. Earnings Per Share, Diluted for the quarter ending February 28, 2025 was -0.15 USD/shares, a 150% decline year-over-year.
- Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2024 was -0.47 USD/shares, a 53.5% increase from 2023.
- Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2023 was -1.01 USD/shares.
- Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2011 was -0.04 USD/shares, unchanged from 2010.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)